Accessibility links
COVID boosters COVID boosters
Stories About

COVID boosters

Friday

Thursday

A pharmacist administers a COVID-19 vaccine.

A new round of COVID-19 vaccines will be rolled out soon. Scott Olson/Getty Images hide caption

toggle caption
Scott Olson/Getty Images

Shots - Health News

The new COVID shot is now available. Here's what you need to know

Two of the updated COVID-19 vaccines have arrived at pharmacies all over the country. On Friday, the FDA authorized the Novavax shot, which is also expected to be available in the coming days.

New COVID Vaccines

Listen · 3:59
Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5082372/nx-s1-ef6edc0b-f1c0-431b-82d8-040da8d937d7" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Sunday

Saturday

Coronavirus FAQ: Are we in a surge? How do you cope if your whole family catches it?

A street painting in Mumbai, India, reinforces the importance of masks amid a surge of COVID. The photo was taken on January 11. Indranil Aditya via Reuters Connect hide caption

toggle caption
Indranil Aditya via Reuters Connect

Goats and Soda

Coronavirus FAQ: Are we in a surge? How do you cope if your whole family catches it?

Are we in a surge? How would we know? Is winter now "COVID season?" And what do you do if your whole family got the coronavirus over the holidays? We tackle readers' coronavirus questions.

Thursday

Wednesday

This year's COVID vaccine rollout is off to a bumpy start, despite high demand

There's high demand for this fall's COVID shots, which offer protection against circulating variants of omicron. But there's been some distribution hiccups. Rogelio V. Solis/AP hide caption

toggle caption
Rogelio V. Solis/AP

Shots - Health News

This year's COVID vaccine rollout is off to a bumpy start, despite high demand

Some people are finding pharmacies still don't have supply of the shots, and others are having insurance coverage troubles. Here's what's going on.

This year's COVID vaccine rollout is off to a bumpy start, despite high demand

  • <iframe src="https://www.npr.org/player/embed/1202055493/1202069348" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Wednesday

The new COVID boosters are coming: Here's what you need to know

Experts say the new COVID boosters are a much closer match to currently circulating variants than prior vaccines and boosters. Frederick J. Brown/AFP via Getty Images hide caption

toggle caption
Frederick J. Brown/AFP via Getty Images

Shots - Health News

The new COVID boosters are coming: Here's what you need to know

Updated versions of the mRNA vaccines roll out this week. Experts say they offer good protection against current COVID variants. Who should get them, and when's the best time to roll up your sleeve?

The new COVID boosters are coming: Here's what you need to know

Listen · 16:20
  • Download
  • <iframe src="https://www.npr.org/player/embed/1198803134/1199473208" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Monday

New COVID vaccines get FDA approval

Another round of COVID-19 vaccines is on the way. The Food and Drug Administration approved vaccines from Pfizer and Moderna that target an omicron subvariant called XBB.1.5. Vaccination campaigns, like this one in San Rafael, Calif., in 2022, could resume soon. Justin Sullivan/Getty Images hide caption

toggle caption
Justin Sullivan/Getty Images

Shots - Health News

New COVID vaccines get FDA approval

Vaccines for a fall immunization drive against COVID-19 just got the green light from the Food and Drug Administration. The agency says the vaccines can protect people, as hospitalizations tick up.

New COVID vaccines get FDA approval

Listen · 4:13
Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1198719166/1198805527" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Some adults can now get a second shot of the bivalent COVID-19 vaccine

Even though the uptake of the omicron booster has been lackluster, federal officials have decided some adults can get a second shot. Scott Olson/Getty Images hide caption

toggle caption
Scott Olson/Getty Images

Shots - Health News

Some adults can now get a second shot of the bivalent COVID-19 vaccine

Older adults and others at high risk are now able to get a second shot of the COVID-19 booster that targets omicron.

Some adults can now get a second shot of the bivalent COVID-19 vaccine

Listen · 3:58
  • Download
  • <iframe src="https://www.npr.org/player/embed/1166629853/1166788630" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Tuesday

When Should I Get My Omicron Booster Shot?
Scott Olson/Getty Images

Short Wave

When Should I Get My Omicron Booster Shot?

Updated COVID boosters are now available that target the Omicron subvariant and many Americans 12 and older are eligible for the shot. Host Emily Kwong and health correspondent Allison Aubrey talk about who should get it, when, and whether there's a case to be made for skipping this booster.

When Should I Get My Omicron Booster Shot?

Listen · 10:49
Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1122439957/1200393626" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

The new COVID booster could be the last you'll need for a year, federal officials say

The new COVID boosters rolling out this month represent a shift in strategy, said White House COVID-19 Response Coordinator Dr. Ashish Jha during a press briefing. The goal now will likely be to roll out new boosters annually. Anna Moneymaker/Getty Images hide caption

toggle caption
Anna Moneymaker/Getty Images

Shots - Health News

The new COVID booster could be the last you'll need for a year, federal officials say

The COVID-19 vaccine strategy may be shifting toward Americans getting yearly vaccinations, like many do with annual flu shots.

The new COVID booster could be the last you'll need for a year, federal officials say

Listen · 3:46
Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1121289835/1121346549" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Monday

Omicron boosters: Do I need one, and if so, when?

Gearing up for fall, health officials are recommending a new round of booster shots. Rogelio V. Solis/AP hide caption

toggle caption
Rogelio V. Solis/AP

Shots - Health News

Omicron boosters: Do I need one, and if so, when?

Updated COVID boosters are now available for anyone age 12 or older. The CDC is urging anyone who is eligible to sign up but some vaccine experts say some people might want to wait.

Omicron boosters: Do I need one, and if so, when?

Listen · 6:15
Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1120834024/1121104618" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Friday

There's no bad time to get a new COVID booster if you're eligible, CDC director says

Rochelle Walensky, director of the Centers for Disease Control and Prevention, attends a Senate hearing in Washington last July. She spoke to NPR shortly after the CDC recommended updated booster shots. Stefani Reynolds/Pool/AFP via Getty Images hide caption

toggle caption
Stefani Reynolds/Pool/AFP via Getty Images

Health

There's no bad time to get a new COVID booster if you're eligible, CDC director says

People can get the Moderna booster if they're 18 or older, and the Pfizer-BioNTech version if they're 12 and up. In both cases, they must wait at least two months since their last COVID vaccine.

There's no bad time to get a new COVID booster if you're eligible, CDC director says

Listen · 5:31
Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1120692856/1120692857" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

FDA authorizes first revamp of COVID vaccines to target omicron

Vials of the newly reformulated COVID-19 vaccine booster are being readied by Pfizer for distribution now that the Food and Drug Administration has authorized the shots for people 12 and older. Pfizer Inc. hide caption

toggle caption
Pfizer Inc.

Shots - Health News

FDA authorizes first revamp of COVID vaccines to target omicron

The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.

Tuesday

Reformulated COVID vaccine boosters may be available earlier than expected

The FDA is trying to make "bivalent" COVID vaccines, which target two different antigens, available as soon as September. Robyn Beck/AFP via Getty Images hide caption

toggle caption
Robyn Beck/AFP via Getty Images

Shots - Health News

Reformulated COVID vaccine boosters may be available earlier than expected

The Biden administration may scrap plans to expand eligibility for second boosters to younger adults. Instead, it's trying to speed up the next generation of boosters targeting the omicron variant.

Reformulated COVID vaccine boosters may be available earlier than expected

Listen · 3:38
Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1113615330/1113615331" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript